药研社 Yaoyanshe

Yaoyanshe is a CRO technology platform that focuses on providing innovative clinical research services for the medical industry. With a patient-centric approach, Yaoyanshe is committed to becoming the warmest and most reliable technological platform in the pharmaceutical R&D ecosystem. Leveraging the core advantages of talent, data, and technology, Yaoyanshe offers one-stop services including CRO, SMO, site start-up (SSU), patient recruitment (PRO), FSP (Functional Service Provider), and intelligent data services to all parties involved in drug development. These services effectively reduce R&D costs and shorten development cycles. The company was founded in 2015 and has received multiple rounds of financing from top-tier investors such as Vision Plus Capital, Matrix Partners China, Genesis Capital, Sequoia Capital, Eastern bell Capital, and GGV Capital. CROCROSMO(SSU)(PRO)(FSP)2015